Dabigatran ‘real world’ experience: insights from New Zealand

A letter to the editor in the New England Journal of Medicine has provided insight into the bleeding risk in the frail elderly of use of dabigatran after the introduction of the drug in New Zealand. The heart.org commentary can be found here.

For those with an iPhone or iPad, there is a freely downloadable app (Managing Dabigatran) aimed help in decision making.

Advertisements